[144] Expensify, Inc. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Expensify, Inc. (EXFY) reports a proposed sale of 5,858 Class A Common shares with an aggregate market value of 11,130.20, scheduled approximately for 09/15/2025 on NASDAQ. The securities were acquired on 09/15/2025 as a combination of a SPMP purchase (3,969 shares) and RSU vesting (1,889 shares), with the stated nature of payment as compensation. The notice identifies prior sales by the same seller, Daniel Vidal, totaling 14,986 shares in the past three months for gross proceeds of 30,515.16. The filer certifies there is no undisclosed material adverse information as of the signature.

Positive

• Required disclosures provided: acquisition dates, nature of acquisition, broker, sale amount, and recent sales with gross proceeds are all included
• Seller made representation that no undisclosed material adverse information is known, which aligns with Rule 144 requirements
• Details on compensation-based acquisition: RSU vesting and SPMP purchase are explicitly recorded

Negative

• Significant recent insider selling: 14,986 shares sold in the past three months for 30,515.16 in gross proceeds, which increases share supply from an insider
• Issuer relationship field is blank: the filing does not state the seller's relationship to the issuer in the Issuer Information section

Insights

Securities Analyst

TL;DR: Insider filing shows additional planned sale after multiple recent dispositions; material for share supply but not a financial performance disclosure.

The Form 144 documents a proposed 5,858-share sale by the reported seller, following 14,986 shares sold in the prior three months. The shares to be sold were acquired on the same date as the planned sale via SPMP purchase and RSU vesting and are described as compensation. For investors, the filing is primarily a liquidity/insider supply signal rather than an operational or earnings disclosure; it does not include any financial results, nor does it state a relationship to the issuer.

Compliance / Risk Analyst

TL;DR: The filing appears procedurally complete and includes the required representation about undisclosed material information.

The notice specifies acquisition details, sale amount, broker, and past three months' sales with gross proceeds, meeting key Rule 144 disclosure elements. It also includes the declarative signature language that the seller is not aware of undisclosed material adverse information. The filing lacks an explicit stated relationship to the issuer in the Issuer Information section, which is left blank in the record provided.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza New York NY 10004	5858	11130.2	80549275	09/15/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Common	09/15/2025	SPMP Purchase	Expensify, Inc.			3969	09/15/2025	Compensation
Class A Common	09/15/2025	RSU Vesting	Expensify, Inc.			1889	09/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Daniel Vidal 401 SW 5th Ave Portland OR 97204	Class A Common	06/17/2025	3354	7647.12
Daniel Vidal 401 SW 5th Ave Portland OR 97204	Class A Common	06/20/2025	1582	3512.04
Daniel Vidal 401 SW 5th Ave Portland OR 97204	Class A Common	08/01/2025	9000	17550
Daniel Vidal 401 SW 5th Ave Portland OR 97204	Class A Common	08/20/2025	1050	1806

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does the Form 144 filed for EXFY report?

It reports a proposed sale of 5,858 Class A Common shares valued at 11,130.20, with an approximate sale date of 09/15/2025 on NASDAQ.

Who is the seller named in the filing?

The filing identifies the seller as Daniel Vidal (address listed) as the person for whose account the securities are to be sold.

How many shares did the seller dispose of in the past three months?

The seller reported sales totaling 14,986 shares on 06/17/2025, 06/20/2025, 08/01/2025, and 08/20/2025 for gross proceeds of 30,515.16.

How were the 5,858 shares being offered acquired?

They were acquired on 09/15/2025 as a combination of a SPMP purchase (3,969 shares) and RSU vesting (1,889 shares), with payment described as compensation.

Which broker is handling the proposed sale?

The broker listed is Morgan Stanley Smith Barney LLC Executive Financial Services at 1 New York Plaza, New York, NY; the exchange named is NASDAQ.